What you should know:
1. Analysts believe the market will grow at a 7.5 percent compound annual growth rate through 2025.
2. Future market growth will be fueled by increased cases of chronic pain, complex regional pain syndrome and failed back syndrome. Heightened awareness of spinal cord stimulation therapy will also contribute to market growth.
3. Key market players include Boston Scientific, Medtronic, Abbott Laboratories, Neurosigma, Nevro, Synapse BioMedical, Integer Holdings, Stimwave Technologies, Nuvectra and Saluda Medical.
More articles on spine:
Would a single-payer system help or hinder spine in the US? 2 neurosurgeons discuss
75 orthopedic, spine device company executive moves in 2019 so far
Spine-focused Altair Health adds Drs. Edward Scheid and Louis Noce
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
